UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer

The Journal of immunology (1950), 2001-01, Vol.166 (1), p.678-689

2001

Volltextzugriff (PDF)

Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells

The Journal of immunology (1950), 2001-05, Vol.166 (9), p.5398-5406

2001

Volltextzugriff (PDF)

Decreased antigen presentation by dendritic cells in patients with breast cancer

Clinical cancer research, 1997-03, Vol.3 (3), p.483-490

1997

Volltextzugriff (PDF)

Antibodies to Vascular Endothelial Growth Factor Enhance the Efficacy of Cancer Immunotherapy by Improving Endogenous Dendritic Cell Function

Clinical cancer research, 1999-10, Vol.5 (10), p.2963-2970

1999

Volltextzugriff (PDF)

Redox phospholipidomics of enzymatically generated oxygenated phospholipids as specific signals of programmed cell death

Free radical biology & medicine, 2020-02, Vol.147, p.231-241

2020

Volltextzugriff (PDF)

An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53

Gene therapy, 2002-03, Vol.9 (5), p.345-352

2002

Volltextzugriff (PDF)

Induction of Potent Human Immunodeficiency Virus Type 1-Specific T-Cell-Restricted Immunity by Genetically Modified Dendritic Cells

Journal of Virology, 2001-08, Vol.75 (16), p.7621-7628

2001

Volltextzugriff (PDF)

Clinical Significance of Defective Dendritic Cell Differentiation in Cancer

Clinical cancer research, 2000-05, Vol.6 (5), p.1755-1766

2000

Volltextzugriff (PDF)

Dendritic cells transduced with wild‐type p53 gene elicit potent anti‐tumour immune responses

Clinical and experimental immunology, 1999-08, Vol.117 (2), p.244-251

1999

Volltextzugriff (PDF)

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

Nature medicine, 1996-10, Vol.2 (10), p.1096-1103

1996

Volltextzugriff (PDF)

Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells

The Journal of immunology (1950), 1998-02, Vol.160 (3), p.1224-1232

1998

Volltextzugriff (PDF)

Combination of γ‐irradiation and dendritic cell administration induces a potent antitumor response in tumor‐bearing mice: Approach to treatment of advanced stage cancer

International journal of cancer, 2001-12, Vol.94 (6), p.825-833

2001

Volltextzugriff (PDF)

Defective Function of Langerhans Cells in Tumor-Bearing Animals Is the Result of Defective Maturation from Hemopoietic Progenitors

The Journal of immunology (1950), 1998-11, Vol.161 (9), p.4842-4851

1998

Volltextzugriff (PDF)

Abstract BS1-2: Myeloid-derived suppressor cells: many facets of regulation of tumor progression

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.BS1-2-BS1-2

Gabrilovich, DI

2018

Volltextzugriff (PDF)

Dendritic Cells in Antitumor Immune Responses: I. Defective Antigen Presentation in Tumor-Bearing Hosts

Cellular immunology, 1996-05, Vol.170 (1), p.101-110

1996

Volltextzugriff (PDF)

Effect of Vascular Endothelial Growth Factor and FLT3 Ligand on Dendritic Cell Generation In Vivo

The Journal of immunology (1950), 1999-09, Vol.163 (6), p.3260-3268

1999

Volltextzugriff (PDF)

Dendritic Cells Transduced with Full-Length Wild-Type p53 Generate Antitumor Cytotoxic T Lymphocytes from Peripheral Blood of Cancer Patients

Clinical cancer research, 2001-01, Vol.7 (1), p.127-135

2001

Volltextzugriff (PDF)

IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer

Journal of immunotherapy (1997), 1996-11, Vol.19 (6), p.414-418

1996

Volltextzugriff (PDF)

Dendritic Cells in Antitumor Immune Responses: II. Dendritic Cells Grown from Bone Marrow Precursors, but Not Mature DC from Tumor-Bearing Mice, Are Effective Antigen Carriers in the Therapy of Established Tumors

Cellular immunology, 1996-05, Vol.170 (1), p.111-119

1996

Volltextzugriff (PDF)

Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34 + progenitor cells

Human immunology, 2001-04, Vol.62 (4), p.332-341

2001

Volltextzugriff (PDF)

STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion

The Journal of immunology (1950), 2005-04, Vol.174 (8), p.4880-4891

2005

Volltextzugriff (PDF)

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

The Journal of clinical investigation, 2010-04, Vol.120 (4), p.1111-1124

2010

Volltextzugriff (PDF)

Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules

Immunology, 1994-05, Vol.82 (1), p.82-87

1994

Volltextzugriff (PDF)

Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species

The Journal of immunology (1950), 2004-01, Vol.172 (2), p.989-999

2004

Volltextzugriff (PDF)

Role of immature myeloid cells in mechanisms of immune evasion in cancer

Cancer Immunology, Immunotherapy, 2006-03, Vol.55 (3), p.237-245

2006

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(153)
Tagungsberichte
(1)

Sprache

Englisch
(129)
Russisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer

Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells

Decreased antigen presentation by dendritic cells in patients with breast cancer

Antibodies to Vascular Endothelial Growth Factor Enhance the Efficacy of Cancer Immunotherapy by Improving Endogenous Dendritic Cell Function

Redox phospholipidomics of enzymatically generated oxygenated phospholipids as specific signals of programmed cell death

An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53

Induction of Potent Human Immunodeficiency Virus Type 1-Specific T-Cell-Restricted Immunity by Genetically Modified Dendritic Cells

Clinical Significance of Defective Dendritic Cell Differentiation in Cancer

Dendritic cells transduced with wild‐type p53 gene elicit potent anti‐tumour immune responses

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells

Combination of γ‐irradiation and dendritic cell administration induces a potent antitumor response in tumor‐bearing mice: Approach to treatment of advanced stage cancer

Defective Function of Langerhans Cells in Tumor-Bearing Animals Is the Result of Defective Maturation from Hemopoietic Progenitors

Abstract BS1-2: Myeloid-derived suppressor cells: many facets of regulation of tumor progression

Dendritic Cells in Antitumor Immune Responses: I. Defective Antigen Presentation in Tumor-Bearing Hosts

Effect of Vascular Endothelial Growth Factor and FLT3 Ligand on Dendritic Cell Generation In Vivo

Dendritic Cells Transduced with Full-Length Wild-Type p53 Generate Antitumor Cytotoxic T Lymphocytes from Peripheral Blood of Cancer Patients

IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer

Dendritic Cells in Antitumor Immune Responses: II. Dendritic Cells Grown from Bone Marrow Precursors, but Not Mature DC from Tumor-Bearing Mice, Are Effective Antigen Carriers in the Therapy of Established Tumors

Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34 + progenitor cells

STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules

Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species

Role of immature myeloid cells in mechanisms of immune evasion in cancer

Suchergebnisse filtern